Rasio utang jangka cendhak marang ekuitas: Grace Therapeutics (GRCE)
Grace Therapeutics, Inc. (GRCE) specializes in therapies for rare nervous system pathologies, utilizing proprietary molecules to expand into global markets. The asset value tracked on this chart currently stands at 0.00. The company attracts top biochemists through a transparent corporate culture and generous stock options. Its R&D strategy is based on adapting known compounds to accelerate FDA approval, creating an efficient pipeline of innovative drugs.
GRCE (Grace Tx): rincian analitis lan laporan miturut indikator
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Grace Therapeutics, Inc.|GRCE - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Grace Therapeutics, Inc.|GRCE - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Grace Therapeutics Inc|GRCE - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Grace Therapeutics|Rasio cepet gracetx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Pambiji fundamental:Grace Therapeutics
Developing unique formulas to cross the blood-brain barrier requires significant capital expenditure, making liquidity control for Grace Therapeutics, Inc. (GRCE) critically important. This metric measures the ratio of short-term liabilities to equity, where reducing the share of short-term loans in equity minimizes bankruptcy risk, while the moderate use of leverage optimizes the company's overall return on assets.
Analisis perusahaan pesaing
Utang jangka cendhak marang modal BIIB|NBIX - Kewajiban jangka cendhak marang modal|Regencell Bioscience - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal axsome.com AXSM|ACAD - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Supernus Corp (SUPN)|CPRX (Catalyst Pharmaceuticals) - Utang jangka cendhak marang modal|DNLI - Tanggungan utang jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Harmony Biosciences Holdings, Inc. (HRMY)|BHVN (Biohaven Ltd) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal AMLX (Amylyx)|Utang jangka cendhak marang modal Trevi Corp TRVI|Praxis Precision Medicines - Utang jangka cendhak marang modal|anavex.com (AVXL) - Rasio utang jangka cendhak marang ekuitas|CBLL: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Prothena Biosciences (PRTA)|Rasio utang jangka cendhak marang ekuitas ALEC|ANNX: Rasio tanggungan utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas OMER (Omeros Corporation)|Rasio silihan jangka cendhak marang modal NGNE|Utang jangka cendhak marang modal ACIU (AC Immune SA)|Rasio tanggungan utang jangka cendhak marang modal VYGR|Neumora Therapeutics Inc - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Scilex Holding Company, Inc.|Tevogen Bio Holdings (TVGN) - Utang jangka cendhak marang ekuitas|Alpha Cognition Inc. - Rasio tanggungan utang jangka cendhak marang modal|CGTX (Cognition Therapeutics, Inc.) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal Inhibikase Therapeutics Inc|Utang jangka cendhak marang ekuitas Cassava (SAVA)|ASRT: Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang modal COYA (Coya Therapeutics)|VistaGen Therapeutics, Inc. (VTGN) - Kewajiban jangka cendhak marang modal|OVID: Rasio utang jangka cendhak marang ekuitas|ABOS - Utang jangka cendhak marang modal|CRVO (CervoMed Inc) - Rasio utang jangka cendhak marang ekuitas|ATHE: Rasio silihan jangka cendhak marang modal|CLNN (Clene Inc) - Utang jangka cendhak marang modal|PepGen Corp (PEPG) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang modal JUNS|Rasio utang jangka cendhak marang ekuitas Relmada Therapeutics Inc RLMD|Utang jangka cendhak marang ekuitas Annovis Bio Corp ANVS|Koefisien utang jangka cendhak marang modal Firefly Neuro (AIFF)|KLTO: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal NRSN (NeuroSense Therapeutics)|RVPH: Utang jangka cendhak marang modal|MTVA - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas NeurAxis, Inc|Rasio utang jangka cendhak marang modal HSDT (Helius Medical Technologies Inc.)|Utang jangka cendhak marang modal PASG|Rasio utang jangka cendhak marang ekuitas bionomics.com.au NEUP|Minerva Neurosciences, Inc. - Rasio utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal Athira Pharma Inc (ATHA)|Addex Therapeutics, Ltd. - Utang jangka cendhak marang modal|Tanggungan utang jangka cendhak marang ekuitas Alzamend Neuro, Inc. (ALZN)|cyclerion.com (CYCN) - Utang jangka cendhak marang ekuitas|Protagenic Therapeutics, Inc. - Rasio tanggungan utang jangka cendhak marang modal|KTTA (Pasithea Therapeutics Corp) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Cortigent Medical (CRGT)|Utang jangka cendhak marang modal ATXI|BCLI - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Cara Therapeutics, Inc. CARA|CHRO: Rasio utang jangka cendhak marang modal|Eliem - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Intra-Cellular Therapies|LBPH (Longboard Pharma) - Rasio utang jangka cendhak marang ekuitas|Marinus Pharma (MRNS) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas NKGen Biotech, Inc.|NRBO: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Sage Therapeutics (SAGE)|SNPX - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal TRVN (Trevena, Inc)|Tanggungan utang jangka cendhak marang ekuitas Vigil Neuroscience Inc.|WENA - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal CERE (cerevel.com)